Bristol (BMY) Shareholder Schmidt P J Investment Management Trimmed Stake by $464,499 as Stock Price Declined; As Apple (AAPL) Share Price Rose, Glenview Capital Management Has Lowered Position

January 19, 2018 - By Michael Collier

Larry Robbins decreased its stake in Apple Inc (AAPL) by 1.59% based on its latest 2017Q3 regulatory filing with the SEC. Glenview Capital Management Llc sold 40,164 shares as the company’s stock rose 12.78% with the market. The hedge fund run by Larry Robbins held 2.49 million shares of the computer manufacturing company at the end of 2017Q3, valued at $383.69 million, down from 2.53 million at the end of the previous reported quarter. Glenview Capital Management Llc who had been investing in Apple Inc for a number of months, seems to be less bullish one the $907.48B market cap company. The stock decreased 0.49% or $0.87 during the last trading session, reaching $178.39. About 19.15 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since January 19, 2017 and is uptrending. It has outperformed by 45.78% the S&P500.

Schmidt P J Investment Management Inc decreased its stake in Bristol (BMY) by 8.11% based on its latest 2017Q3 regulatory filing with the SEC. Schmidt P J Investment Management Inc sold 7,373 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 83,506 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.32M, down from 90,879 at the end of the previous reported quarter. Schmidt P J Investment Management Inc who had been investing in Bristol for a number of months, seems to be less bullish one the $101.46 billion market cap company. The stock increased 0.26% or $0.16 during the last trading session, reaching $61.99. About 5.01 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 19, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Among 52 analysts covering Apple Inc. (NASDAQ:AAPL), 39 have Buy rating, 1 Sell and 12 Hold. Therefore 75% are positive. Apple Inc. had 350 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Wednesday, June 21 by Cowen & Co. The rating was maintained by Piper Jaffray on Friday, August 14 with “Overweight”. On Wednesday, October 12 the stock rating was maintained by Mizuho with “Buy”. The firm has “Buy” rating given on Tuesday, August 22 by Canaccord Genuity. Canaccord Genuity maintained Apple Inc. (NASDAQ:AAPL) on Monday, September 21 with “Buy” rating. The firm earned “Buy” rating on Tuesday, October 31 by Piper Jaffray. Morgan Stanley maintained it with “Overweight” rating and $154 target in Tuesday, February 21 report. The firm has “Overweight” rating given on Wednesday, July 27 by Morgan Stanley. Macquarie Research maintained Apple Inc. (NASDAQ:AAPL) rating on Tuesday, August 11. Macquarie Research has “Outperform” rating and $140 target. Mizuho maintained Apple Inc. (NASDAQ:AAPL) on Wednesday, October 28 with “Hold” rating.

Since August 7, 2017, it had 0 buys, and 12 sales for $93.68 million activity. AHRENDTS ANGELA J also sold $9.78 million worth of Apple Inc. (NASDAQ:AAPL) shares. The insider FEDERIGHI CRAIG sold $9.98M. On Monday, August 28 the insider Srouji Johny sold $948,612. 15,641 shares valued at $2.73M were sold by Riccio Daniel J. on Friday, January 5. 35,000 shares valued at $5.52 million were sold by LEVINSON ARTHUR D on Monday, August 7. 268,623 shares valued at $43.15 million were sold by COOK TIMOTHY D on Thursday, August 24.

Glenview Capital Management Llc, which manages about $13.95 billion and $17.23B US Long portfolio, upped its stake in Endo Intl Plc (NASDAQ:ENDP) by 574,871 shares to 10.95 million shares, valued at $93.82M in 2017Q3, according to the filing. It also increased its holding in Mckesson Corp (NYSE:MCK) by 1.53M shares in the quarter, for a total of 2.72M shares, and has risen its stake in Universal Hlth Svcs Inc (NYSE:UHS).

Investors sentiment increased to 0.7 in Q3 2017. Its up 0.02, from 0.68 in 2017Q2. It improved, as 52 investors sold AAPL shares while 1034 reduced holdings. 116 funds opened positions while 640 raised stakes. 2.97 billion shares or 2.78% less from 3.06 billion shares in 2017Q2 were reported. Cincinnati Ins Comm owns 154,000 shares or 0.71% of their US portfolio. Gratry Communications Ltd Company has invested 0.69% of its portfolio in Apple Inc. (NASDAQ:AAPL). 26,974 are owned by Alps. State Board Of Administration Of Florida Retirement Sys accumulated 7.55 million shares. Moreover, Metropolitan Life Insur Commerce New York has 2.58% invested in Apple Inc. (NASDAQ:AAPL). Huntington Bancorporation owns 1.88% invested in Apple Inc. (NASDAQ:AAPL) for 722,979 shares. Steinberg Global Asset Mngmt holds 35,087 shares. Texas-based Stanley Cap Management Ltd Liability Company has invested 4.54% in Apple Inc. (NASDAQ:AAPL). Thompson Davis Incorporated accumulated 6,154 shares or 1.68% of the stock. Kwmg Limited Co reported 0.16% of its portfolio in Apple Inc. (NASDAQ:AAPL). Guardian LP invested in 188,561 shares or 0.43% of the stock. Symmetry Peak Mgmt Ltd Limited Liability Company owns 10,000 shares. Hikari Pwr Ltd holds 1,350 shares or 0.03% of its portfolio. 1,214 are owned by American Beacon Advsrs. Cumberland Prns invested in 86,819 shares or 1.8% of the stock.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on January, 30. They expect $3.75 earnings per share, up 11.61% or $0.39 from last year’s $3.36 per share. AAPL’s profit will be $19.08 billion for 11.89 P/E if the $3.75 EPS becomes a reality. After $2.07 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts 81.16% EPS growth.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 25. They expect $0.67 EPS, up 6.35% or $0.04 from last year’s $0.63 per share. BMY’s profit will be $1.10B for 23.13 P/E if the $0.67 EPS becomes a reality. After $0.75 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -10.67% negative EPS growth.

Schmidt P J Investment Management Inc, which manages about $434.11M and $334.21M US Long portfolio, upped its stake in Amazon.Com Inc (NASDAQ:AMZN) by 1,769 shares to 3,187 shares, valued at $3.06 million in 2017Q3, according to the filing.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. E&G Advsrs Lp invested in 6,316 shares or 0.18% of the stock. 15,518 are held by Tt. 69,062 were accumulated by Hartford Financial Inc. Northern Trust Corporation reported 24.63M shares. 41,033 are owned by National Bank & Trust. Accredited Invsts stated it has 0.26% in Bristol-Myers Squibb Company (NYSE:BMY). Northstar Invest Advisors Limited Company reported 0.64% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Glenmede Trust Na holds 0.11% or 401,144 shares in its portfolio. Nadler Fin Gru holds 0.13% in Bristol-Myers Squibb Company (NYSE:BMY) or 6,222 shares. Dekabank Deutsche Girozentrale has invested 0.44% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Balasa Dinverno Foltz holds 25,870 shares. Banque Pictet & Cie Sa owns 20,850 shares. Moreover, Private Wealth Inc has 0.13% invested in Bristol-Myers Squibb Company (NYSE:BMY). Ashfield Cap Partners Limited invested in 0.22% or 26,111 shares. Nationwide Fund Advsr accumulated 1.23 million shares.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Sell” rating and $4700 target in Monday, June 5 report. Cowen & Co maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Monday, July 10. Cowen & Co has “Hold” rating and $6500 target. On Friday, September 15 the stock rating was maintained by Jefferies with “Buy”. As per Friday, October 6, the company rating was maintained by UBS. Barclays Capital maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Friday, April 29. Barclays Capital has “Equal Weight” rating and $75 target. The rating was upgraded by Jefferies on Monday, December 19 to “Buy”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Tuesday, June 14 by Jefferies. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by UBS on Tuesday, September 29. BMO Capital Markets downgraded the shares of BMY in report on Monday, January 25 to “Market Perform” rating. Barclays Capital maintained the shares of BMY in report on Tuesday, December 1 with “Equal Weight” rating.

Since September 6, 2017, it had 1 insider purchase, and 2 selling transactions for $646,385 activity. Another trade for 4,000 shares valued at $249,187 was made by Samuels Theodore R. II on Friday, December 15. Caldarella Joseph C also sold $560,400 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts